Kuhdari, Parvanè
Brosio, Federica
Malaventura, Cristina
Stefanati, Armando
Orsi, Andrea
Icardi, Giancarlo
Gabutti, Giovanni
Article History
Received: 23 November 2017
Accepted: 23 April 2018
First Online: 4 May 2018
Ethics approval and consent to participate
: HDRs were provided by the National Archive of SDO data, Ministry of Health, General Directorate of Healthcare Planning, VI Office. For this type of retrospective study formal consent is not required; any personal data was protected accordingly to the Helsinki Declaration and to the Italian law (Legislative Decree of 30 June 2003, n. 196. Code on the protection of personal data).
: GG received grants from GlaxoSmithKline Biologicals SA, Sanofi Pasteur MSD, Novartis, Crucell/Janssen, Seqirus, Sanofi Pasteur, Merck Italy, Pfizer and PaxVax for being consultant or taking part in advisory board, expert meetings, being a speaker or an organizer of congresses/conferences, and acting as investigator in clinical trials. GI reports grants from Sanofi Pasteur, MSD, GSK, Novartis and Pfizer for taking part to advisory boards, expert meetings, for acting as speaker and/or organizer of meetings/congresses and as principal investigator and chief of O.U. in RCTs. AO has previously participated in speaker’s bureaux and advisory board meetings sponsored by Sanofi Pasteur and MSD. Other authors have no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.